Eris Lifesciences Competitors and Similar CompaniesClear all

Eris Lifesciences's competitors and similar companies include Lipogen, InnoPep, BERLIN-CHEMIE and Yabao Pharmaceutical.

	Eris Lifesciences Eris Lifesciences is a company specializing in the chronic and acute therapy segments.	Lipogen Lipogen is a company that manufactures and distributes phospholipids for stress management and cognitive function support.	InnoPep InnoPep is a company that specializes in peptide synthesis and conjugation.	BERLIN-CHEMIE BERLIN-CHEMIE is a pharmaceutical company that specializes in the development, manufacturing, and distribution of drugs.	Yabao Pharmaceutical Yabao Pharmaceutical Group ( 亚宝药业) is a company that specializes in the production, logistics, and distribution of medicines.
Founding Date	Founding Date 2007	Founding Date 1991	Founding Date N/A	Founding Date 1886	Founding Date 1978
Type	Type Public	Type Private	Type Private	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech distribution drug development ecommerce pharma	Tags Healthcare biotech distribution drug development ecommerce pharma	Tags Healthcare biotech distribution drug development ecommerce pharma	Tags Healthcare biotech distribution drug development pharma	Tags Healthcare biotech distribution drug development pharma
Locations	Locations Ahmedabad, IN HQ Ambala Cantt, IN Guwahati, IN Mumbai, IN	Locations South Portland, US HQ	Locations San Diego, US HQ	Locations Berlin, DE HQ	Locations Yuncheng Shi, CN HQ Beijing, CN Yuncheng, CN Yuncheng Shi, CN
Employees	Employees 3,620	Employees 13	Employees N/A	Employees 5,289	Employees 3,611
Financial
Revenue (est.)	Revenue (est.) ₹28.8b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥2.2b (FY, 2025)
Cost of goods	Cost of goods ₹7.3b (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥1.1b (FY, 2025)
Gross profit	Gross profit ₹21.7b (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥1.1b (FY, 2025)
Net income	Net income ₹3.7b (FY, 2025)	Net income N/A	Net income N/A	Net income N/A	Net income ¥299.9m (FY, 2025)